Clinuvel Pharmaceuticals Ltd
ASX:CUV
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Price:
15.9 AUD
5.02%
Market Closed
Updated:
Jun 1, 2024
Clinuvel Pharmaceuticals Ltd
Net Change in Cash
|
Clinuvel Pharmaceuticals Ltd
Net Change in Cash Peer Comparison
Comparables:
IMM
MSB
CSL
TLX
PYC
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Net Change in Cash
AU$44.9m
|
CAGR 3-Years
43%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Immutep Ltd
ASX:IMM
|
Net Change in Cash
AU$43.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
29%
|
CAGR 10-Years
21%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Net Change in Cash
$9.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Net Change in Cash
-$446.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-22%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Net Change in Cash
AU$6.9m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Net Change in Cash
AU$8.3m
|
CAGR 3-Years
33%
|
CAGR 5-Years
8%
|
CAGR 10-Years
23%
|
See Also
What is Clinuvel Pharmaceuticals Ltd's Net Change in Cash?
Net Change in Cash
44.9m
AUD
44.9m
AUD
Based on the financial report for Dec 31, 2023, Clinuvel Pharmaceuticals Ltd's Net Change in Cash amounts to 44.9m AUD.
What is Clinuvel Pharmaceuticals Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
25%
25%
Over the last year, the Net Change in Cash growth was 127%. The average annual Net Change in Cash growth rates for Clinuvel Pharmaceuticals Ltd have been 43% over the past three years , 25% over the past five years .
You don't have any saved screeners yet
